Back to search

Duquesne

Clinical, Economic, and Humanistic Impact of Sofosbuvir-Based Regimens in Hepatitis C

Abstract

dc:description.abstract

Objective: A retrospective data analysis was conducted on real-world data for treatment-naïve and treatment-experienced patients with hepatitis C. Real-world effectiveness values were used to populate an economic model for genotype 1 patients with hepatitis C. Methods: De-identified data of patients using FDA-approved, sofosbuvir-based regimens from Walgreens Specialty Pharmacy (December 2013 – April 30, 2015) was utilized. The study was conducted in two phases. In Phase I, an economic model was adapted from literature to estimate real-world cost effectiveness ratios of sofosbuvir-based regimens compared to telaprevir-based regimen. Real-world effectiveness values derived from Phase II analysis was used to populate the economic model. In Phase II, descriptive analyses were conducted to evaluate treatment utilization patterns of sofosbuvir-based regimens. Medication adherence was assessed using pharmacy refill data by medication possession ratio and proportion of days covered methods. Factors associated with treatment discontinuation were also assessed. Results: Sofosbuvir-based regimens led to cost savings for treatment-naïve and treatment-experienced genotype 1 patients compared to telaprevir-based regimen. The majority of patients in this study were adherent to sofosbuvir-based regimens and the overall discontinuation rates in the study were low. Of the patients that discontinued therapy, the primary reported reasons were side effects and insurance coverage issues. Treatment discontinuation due to side effects was highest in patients using peg-interferon-based, sofosbuvir regimen. Conclusions: Sofosbuvir-based regimens are cost-effective, with most patients being adherent to their regimen in this real-world study.

Degree

thesis:*
Name thesis:degree_name
MS
Level thesis:degree_level
Immediate Access
Discipline thesis:degree_discipline
Pharmacy Administration

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Parekh, Mousam
Contributors dc:contributor
  • Khalid Kamal
  • Pamela Koerner
  • Richard Miller
  • Vincent Giannetti

Subjects

dc:subject × 4

Rights

Language dc:language
English

Identifiers

dc:identifier.*
Repository record dc:identifier
https://dsc.duq.edu/etd/1506

Chain of custody

source
Harvested from
Duquesne
Base URL
dsc.duq.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Parekh, Mousam. Clinical, Economic, and Humanistic Impact of Sofosbuvir-Based Regimens in Hepatitis C. Immediate Access thesis, https://dsc.duq.edu/etd/1506